Newsroom | 230325 results

GALASHIELS, Scotland & MARLOW, England--(BUSINESS WIRE)--Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum to Host Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of one-year results from the pivotal Phase 2b/3 BRUNELLO trial evaluating remigromig (MK-3000, formerly EYE103), an investigational, potentially first-in-class tetravalent, tri-specific antibody designed to activate the Wingless-related integration site (Wnt) pathway, for the treatment of diabetic macular edema (DME). Results were presented today at the...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today new one-year data from the Phase III MEERKAT and SANDCAT studies evaluating investigational vamikibart compared with a sham procedure that mimics intravitreal (IVT) injections in adults with uveitic macular edema (UME). Across both studies, data continue to support the potential for rapid and sustained improvements in vision and reductions in macular thickness (swel...

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Verda Healthcare, Inc. is proud to announce a new partnership with AstranaCare Partners of Arizona and AstranaCare Partners of Texas. AstranaCare, through a large network of Independent Physician Associations (IPAs), enables providers to deliver high-quality care, efficiently with supportive local resources and technology tools that allow providers to focus more on patient care rather than administrative tasks. Astrana Health, the parent company, has o...

VALENCIA, Spain--(BUSINESS WIRE)--Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precis...

LAS VEGAS--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest nonprofit public health organization, is debuting a new environmentally friendly, electric mobile (EV) unit to increase access to free testing, prevention and treatment services for sexually transmitted infections (STI), including gonorrhea, chlamydia, syphilis and HIV. As the first nonprofit public health organization to launch the all-in-one, "wellness on wheels" concept, the organization will unveil its new veh...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--On August 10, an unauthorized actor exploited a critical vulnerability in the Metabase platform to obtain administrator access to Blueberry’s Metabase environment. The activity was associated with broader exploitation of the Metabase vulnerability. On August 22, Blueberry detected the unauthorized access and initiated its incident-response process. Within approximately one hour of detection, Blueberry terminated the unauthorized access and associated sess...

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics, Inc., the global specialty pharmaceutical business of Tokyo-based Asahi Kasei, with U.S. and European business headquarters in Cary, North Carolina, today announced that the U.S. Food and Drug Administration (FDA) has approved HOVILPRI® (pritelivir) 100 mg tablets for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection that is refractory (with or without documented resistance) to treatment with acyclovir, valacy...

LAS VEGAS--(BUSINESS WIRE)--'Pride on Paradise' Festival Returns Oct. 10 with Plastique Tiara, Adore Delano, Juicy Love Dion, and More...